Compare TV & PRGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TV | PRGO |
|---|---|---|
| Founded | 1969 | 1887 |
| Country | Mexico | Ireland |
| Employees | 26599 | N/A |
| Industry | Broadcasting | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.6B |
| IPO Year | N/A | 2013 |
| Metric | TV | PRGO |
|---|---|---|
| Price | $2.61 | $10.34 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 4 | 3 |
| Target Price | $5.30 | ★ $19.33 |
| AVG Volume (30 Days) | 1.0M | ★ 2.5M |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | 2.83% | ★ 10.28% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $800,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.02 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.96 | $9.23 |
| 52 Week High | $3.49 | $28.44 |
| Indicator | TV | PRGO |
|---|---|---|
| Relative Strength Index (RSI) | 31.74 | 39.37 |
| Support Level | $2.55 | $9.24 |
| Resistance Level | $2.95 | $12.36 |
| Average True Range (ATR) | 0.09 | 0.45 |
| MACD | -0.02 | -0.07 |
| Stochastic Oscillator | 15.71 | 9.12 |
Televisa is one of the leading telecom firms in Mexico. Its cable arm, Izzi, holds networks that pass 20 million Mexican homes and provide broadband service to nearly 6 million customers. The firm is also one of the largest pay-television providers in Mexico, with nearly 4 million customers. Televisa owns Sky Mexico, the country's only satellite-TV provider, serving about 4 million customers. After merging its traditional media business into Univision, Grupo Televisa owns a 43% stake in the combined entity TelevisaUnivision. Grupo Televisa spun off several smaller businesses, including magazine publishing, three of Mexico's professional soccer teams, and Azteca Stadium in February 2024, under the name Ollamani.
Perrigo is one of the largest consumer health companies in the world. Since 2018, Perrigo has divested its animal health and generic pharmaceuticals businesses to solely focus on consumer self-care. In North America (two-thirds of total sales), the firm's product mix is anchored in private-label consumer health goods, which are sold to major retailers like Walmart, Amazon, Costco, and CVS. Perrigo also plays in Europe, Australia, and parts of Asia where it primarily generates revenue through its national brands, including Compeed, Solpadeine, Coldrex, and ellaOne.